Purple Biotech (PPBT) Profit After Tax (2014 - 2026)
Purple Biotech (PPBT) reported Profit After Tax of -$89000.0 for Q1 2026, down 119.52% year-over-year from $456000.0 in Q1 2025, and down 100.38% quarter-over-quarter from $23.6 million in Q4 2025.
Purple Biotech (PPBT) Profit After Tax (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Profit After Tax data on file, last reported at -$89000.0 in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$89000.0, down 119.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (up 556.22% YoY), and the FY2025 annual result was -$26.5 million, down 263.95% from the prior year.
- Profit After Tax eased to -$89000.0 in Q1 2026 per PPBT's latest filing, from $23.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $23.6 million in Q4 2025 and troughed at -$7.3 million in Q1 2022.
- A 5-year average of $2.3 million and a median of $1.3 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax sank 213.73% in 2022, then surged 5596.87% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$6.0 million in 2022, then jumped by 180.41% to $4.9 million in 2023, then plunged by 91.46% to $415000.0 in 2024, then surged by 5596.87% to $23.6 million in 2025, then slumped by 100.38% to -$89000.0 in 2026.
- Business Quant data shows PPBT's Profit After Tax at -$89000.0 in Q1 2026, $23.6 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89,000.00 |
| Dec 31, 2025 | 23.64 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 415,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 3.78 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | -6.04 Mn |
| Sep 30, 2022 | 4.85 Mn |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | -7.32 Mn |
| Dec 31, 2021 | -4.75 Mn |
| Sep 30, 2021 | 3.15 Mn |
| Jun 30, 2021 | 3.64 Mn |